Literature DB >> 11840237

Hidden morbidity with "successful" early discharge.

Paula Radmacher1, Christopher Massey, David Adamkin.   

Abstract

OBJECTIVE: This study was conducted to determine if early postnatal discharge (EDC; < or =48 hours) in well newborns had an effect on the rate of hospital readmission within the first week after hospital discharge when compared to infants who remained >48 hours after birth (later discharge, LDC). STUDY
DESIGN: This was a retrospective medical chart review. Charts of infants born between January 1994 and December 1998, discharged as "well newborns" and treated subsequently at a primary children's hospital within 7 days of neonatal discharge, were reviewed. Infants were categorized by length of neonatal hospital stay, level of medical intervention (emergency department treatment or hospital admission), and final diagnosis.
RESULTS: There was a significant increase in hospital readmission rate for LDC infants when compared to EDC infants. When considering jaundice alone as an admitting diagnosis, EDC infants were admitted at a higher rate than LDC infants and with higher serum bilirubin concentrations. Readmitted, jaundiced infants had been almost always breast-fed.
CONCLUSION: Overall, EDC of well newborns appears to be a safe and reasonable practice. However, the risk for severe jaundice is an unresolved issue that requires a discharge strategy and early follow-up to prevent serious morbidity.

Entities:  

Mesh:

Year:  2002        PMID: 11840237     DOI: 10.1038/sj.jp.7210586

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  2 in total

Review 1.  Neonatal hyperbilirubinemia and early discharge from the maternity ward.

Authors:  Daniele De Luca; Virgilio P Carnielli; Piermichele Paolillo
Journal:  Eur J Pediatr       Date:  2009-03-11       Impact factor: 3.183

2.  Early discharge and readmission to hospital in the first month of life in the Northern Region of the UK during 1998: a case cohort study.

Authors:  S J Oddie; D Hammal; S Richmond; L Parker
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.